Related content

Interpretation and use of FRAX in clinical practice

By Kanis J.   Hans D.   Cooper C.   Baim S.   Bilezikian J.   Binkley N.   Cauley J.   Compston J.   Dawson-Hughes B.   El-Hajj Fuleihan G.   Johansson H.   Leslie W.   Lewiecki E.   Luckey M.   Oden A.   Papapoulos S.   Poiana C.   Rizzoli R.   Wahl D.   McCloskey E.  

Osteoporosis International, Vol. 22, Iss. 9, 2011-09 ,pp. : 2395-2411

Springer Publishing Company

Access to resources Recommend Favorite

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)

By Fujiwara S.   Nakamura T.   Orimo H.   Hosoi T.   Gorai I.   Oden A.   Johansson H.   Kanis J.  

Osteoporosis International, Vol. 19, Iss. 4, 2008-04 ,pp. : 429-435

Springer Publishing Company

Access to resources Recommend Favorite

The use of multiple sites for the diagnosis of osteoporosis

By Kanis J.   Johnell O.   Oden A.   Johansson H.   Eisman J.   Fujiwara S.   Kroger H.   Honkanen R.   Melton L.   O’Neill T.   Reeve J.   Silman A.   Tenenhouse A.  

Osteoporosis International, Vol. 17, Iss. 4, 2006-04 ,pp. : 527-534

Springer Publishing Company

Access to resources Recommend Favorite

Long-term use of bisphosphonates in osteoporosis

By Rizzoli René  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 309-315

Future Medicine

Access to resources Recommend Favorite

Osteoporosis: Pathophysiology and new drug development

By Vondracek Sheryl   Chen Judy   Csako Gyorgy  

Clinical Review in Bone and Mineral Metabolism, Vol. 2, Iss. 4, 2004-12 ,pp. : 293-313

Humana Press, Inc

Access to resources Recommend Favorite